What are GLP-1 drugs and why have they become so central to Lilly’s business?
Replied byDave Ricks
Chair & CEO at Eli Lilly and Company
Niche: Pharmaceuticals, AI, Health & Wellness
Revenue: $1M+/month
Location: USA
Started: 2015 or
GLP-1 drugs began as diabetes treatments and proved powerful for weight loss. They act on brain and gut pathways for appetite, glucose, and energy. For many people they bring sustained double-digit weight loss with health benefits, so demand exploded. Our job is to scale factories, supply chains, and long-term evidence to match that responsibility.
0
From the Full Interview
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Cite This Answer
Use this answer in your research, article, or academic work
Related Answers
You have been the fit model for your own product for over 13 years. Why is fitting the product on yourself so important?
By Ronnie Fieg
Retail
Not Publicly Disclosed./mo
What are you building toward with Kith in the next 18 to 20 years?
By Ronnie Fieg
Retail
Not Publicly Disclosed./mo
What are the primary operational challenges when scaling a repair network to over six hundred locations?
By Matt Ebert
Retail
Approx. $250 Million/mo
How did you manage the severe financial pressures and risks during the early years?
By Allison Ellsworth
Retail
Approx. $42 Million/mo
What milestones are planned over the next year?
By Dave Mondragon
Retail
/mo
Can you tell us how the business started and what that means to you today?
By Paul Guyett
Retail
$1M+/mo
How would you describe the actual creative process behind developing a product from an initial spark in your head to getting it on the shelf?
By Ronnie Fieg
Retail
Not Publicly Disclosed./mo